Dynamic susceptibility contrast perfusion weighted imaging in grading of nonenhancing astrocytomas.
about
Principles of T2 *-weighted dynamic susceptibility contrast MRI technique in brain tumor imaging.Discrimination between glioma grades II and III in suspected low-grade gliomas using dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging: a histogram analysis approach.Relative cerebral blood volume from dynamic susceptibility contrast perfusion in the grading of pediatric primary brain tumors.The role of imaging in the management of adults with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.Contrast Leakage Patterns from Dynamic Susceptibility Contrast Perfusion MRI in the Grading of Primary Pediatric Brain Tumors.Advanced MR imaging techniques in the evaluation of nonenhancing gliomas: perfusion-weighted imaging compared with proton magnetic resonance spectroscopy and tumor gradeDiscriminating radiation necrosis from tumor progression in gliomas: a systematic review what is the best imaging modality?The Role of preload and leakage correction in gadolinium-based cerebral blood volume estimation determined by comparison with MION as a criterion standardMRI in Glioma Immunotherapy: Evidence, Pitfalls, and Perspectives.Prognostic Value of Dynamic Susceptibility Contrast-Enhanced and Diffusion-Weighted MR Imaging in Patients with Glioblastomas.Advanced MRI may complement histological diagnosis of lower grade gliomas and help in predicting survival.Differentiation between oligodendroglioma genotypes using dynamic susceptibility contrast perfusion-weighted imaging and proton MR spectroscopy.Quantitative magnetic resonance imaging biomarkers in oncological clinical trials: Current techniques and standardization challenges.Imaging in neuro-oncology.Brain Tumor Characterization Using Multibiometric Evaluation of MRI.Preoperative grading of supratentorial nonenhancing gliomas by high b-value diffusion-weighted 3 T magnetic resonance imaging.
P2860
Q30818733-AE90FB13-979E-4BEE-9BAF-D568BA785589Q30849400-4782EA45-BD08-4EB1-B2B9-ED4348A9B30FQ30878032-3853B071-69B1-47C3-A5CD-1F9D301301E2Q31016200-693C95CB-56D6-4EF7-8F65-97D0BC8EC5ABQ31022764-A62E1EDC-C738-452E-ADD8-CD7286B3A01BQ34369508-9B9401EF-3EAC-4837-AE5B-2A0A752B16FAQ34560322-827B24AB-C045-434C-A014-1D5E2FAC8741Q35090720-ABA08085-9DCC-4D55-B035-F642B66B287CQ39312420-D99FBF75-9126-4196-A01F-74C1BD42F58AQ41120949-1CB3F828-A2E8-4F11-B2F6-6BC01ACCA917Q41220218-23EAE15C-A672-42CC-8658-2A5C23238DB1Q48182114-DE428535-F45B-44B9-8B25-89418DFE2683Q52904949-C1763B06-A96A-4203-A0DE-1DCD1F591737Q54973707-E8B7FA3F-6336-4990-BACD-E490498EC4E6Q55398086-E429AF8E-49C3-41F5-928E-DAEA80C463CEQ55458446-0E5D1384-D467-4BE7-982E-8B76F7F28DC7
P2860
Dynamic susceptibility contrast perfusion weighted imaging in grading of nonenhancing astrocytomas.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Dynamic susceptibility contras ...... of nonenhancing astrocytomas.
@en
Dynamic susceptibility contras ...... of nonenhancing astrocytomas.
@nl
type
label
Dynamic susceptibility contras ...... of nonenhancing astrocytomas.
@en
Dynamic susceptibility contras ...... of nonenhancing astrocytomas.
@nl
prefLabel
Dynamic susceptibility contras ...... of nonenhancing astrocytomas.
@en
Dynamic susceptibility contras ...... of nonenhancing astrocytomas.
@nl
P2093
P2860
P356
P1476
Dynamic susceptibility contras ...... g of nonenhancing astrocytomas
@en
P2093
Elias R Melhem
Naomi Morita
Sanjeev Chawla
Sumei Wang
P2860
P304
P356
10.1002/JMRI.22324
P577
2010-10-01T00:00:00Z